Publications by authors named "Kevin Gillman"

Claim this Profile
D
Diversity-Oriented C-H Activation Reactions of the Naphthalene Scaffold.
Zhoulong Fan, Md Emdadul Hoque, Kevin Wu, Maximilian D Palkowitz, Upender Velaparthi, Kevin W Gillman

J Am Chem Soc· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nickel-Electrocatalytic Decarboxylative Arylation to Access Quaternary Centers.
Gabriele Laudadio, Philipp Neigenfind, Áron Péter, Camille Z Rubel, Megan A Emmanuel, Kevin W Gillman

Angew Chem Int Ed Engl· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XEN 45 Gel Stent Implantation in Open Angle Glaucoma: 5-Year Results of a Prospective Study.
Julien Torbey, Archibald Paillard, Harsha L Rao, Kevin Gillman, Giorgio E Bravetti

J Glaucoma· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Indazoles as Potent, Orally Active Dual Neurokinin 1 Receptor Antagonists and Serotonin Transporter Inhibitors for the Treatment of Depression.
Andrew P Degnan, George O Tora, Hong Huang, David A Conlon, Carl D Davis, Kevin W Gillman

ACS Chem Neurosci· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biaryls as potent, tunable dual neurokinin 1 receptor antagonists and serotonin transporter inhibitors.
Andrew P Degnan, George O Tora, Ying Han, Ramkumar Rajamani, Robert Bertekap, Kevin W Gillman

Bioorg Med Chem Lett· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of carbon-14 and stable isotope labeled Avagacestat: a novel gamma secretase inhibitor for the treatment of Alzheimer's disease.
Richard C Burrell, John A Easter, Michael P Cassidy, Kevin W Gillman, Richard E Olson

J Labelled Comp Radiopharm· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NK1 receptor antagonism lowers occupancy requirement for antidepressant-like effects of SSRIs in the gerbil forced swim test.
Snjezana Lelas, Yu-Wen Li, Tanya L Wallace-Boone, Matthew T Taber, Amy E Newton, Kevin W Gillman

Neuropharmacology· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamics of selective inhibition of γ-secretase by avagacestat.
Charles F Albright, Randy C Dockens, Jere E Meredith, Richard E Olson, Randy Slemmon, Kevin W Gillman

J Pharmacol Exp Ther· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, optimization, and in vivo evaluation of a series of pyridine derivatives with dual NK1 antagonism and SERT inhibition for the treatment of depression.
Kevin W Gillman, Michael F Parker, Mark Silva, Andrew P Degnan, George O Tora

Bioorg Med Chem Lett· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor.
Kevin W Gillman, John E Starrett, Michael F Parker, Kai Xie, Joanne J Bronson

ACS Med Chem Lett· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping.
Mark D Lindner, John B Hogan, Donald B Hodges, Anitra F Orie, Ping Chen, Kevin W Gillman

Psychopharmacology (Berl)· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists.
Kevin W Gillman, Mendi A Higgins, Graham S Poindexter, Marc Browning, Wendy J Clarke

Bioorg Med Chem· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning.
Mark D Lindner, Donald B Hodges, John B Hogan, Anitra F Orie, Jason A Corsa, Kevin W Gillman

J Pharmacol Exp Ther· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis